The anti-malarial drug Artemisinin is highly effective. It's critical for kids, who are especially vulnerable. A new study ...

Between treating patients, she says, they voice their concerns: "'Malaria's very stubborn,'" she says they tell her. "'It's not responding to treatment.'" Namazzi is a pediatrician at Mulago ...

A new study comes to an alarming... What's going on with the 'magic' drug for malaria? Lately, Dr. Ruth Namazzi and her colleagues have been stopping one another in their hospital ward with ...

Oct. 23, 2024 — Maternal antibodies passed across the placenta can interfere with the response to the malaria vaccine, which would explain its lower efficacy in infants under five months of age ...

The vector-borne disease is caused by caused by the malaria parasite Plasmodium falciparum. (Image Credits: Pixabay) A new study from Uganda provides the first evidence to date that resistance to ...

A new study has revealed alarming evidence of partial resistance to artemisinin, a crucial antimalarial drug, in Ugandan children with severe malaria. This resistance could hinder the ...

THURSDAY, Nov. 14, 2024 (HealthDay News) -- Over 600,000 people worldwide die from mosquito-borne malaria each year, with the majority of these deaths happening among children under 5. Now ...

Opens in a new tab or window Partial resistance to artemisinin, the recommended treatment for Plasmodium falciparum malaria, occurred in Ugandan children with severe disease who were treated with ...